mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.062 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |